CIBA HEALTH AUTHENTICATED BY THE VALIDATION INSTITUTE FOR CLINICAL AND FINANCIAL OUTCOMES
CIBA HEALTH AUTHENTICATED BY THE VALIDATION INSTITUTE FOR CLINICAL AND FINANCIAL OUTCOMES ACROSS ITS INTEGRATIVE CARE PROGRAM
An independent report confirms that a root-cause digital health platform improves clinical outcomes and reduces costs, including impact on GLP-1 medication use.
New York, NY (August 19, 2025) — Ciba Health, a leading digital health company specializing in personalized, outcomes-driven care for polychronic conditions, has been recognized by the Validation Institute for the clinical efficacy and financial value of its care model. The Validation Institute’s third-party, independent evaluation confirms that Ciba Health’s AI-powered, integrative platform is improving patient health while also reducing healthcare costs – a vital advancement as employers, health plans, health systems, TPAs, providers and patients seek scalable, evidence-backed treatment for chronic conditions.
Ciba Health is redefining care by identifying and addressing the root causes of complex chronic conditions, such as type 2 diabetes, obesity, autoimmune conditions, digestive disorder, and mental health challenges. The model integrates metabolic, hormonal, digestive, and behavioral insights to deliver sustainable health outcomes, without reliance on long-term pharmacotherapy.
The 2025 Validation Report confirms that Ciba Health’s digitally delivered care model drives measurable clinical and financial outcomes.
Within 12 months, Ciba Health prevented and reversed common and complex chronic conditions, delivering both cost savings and improved patient health. Key outcomes include:
- 44% reduction in annual drug costs among program participants
- 85% reduction in overall medication use
- 90% of patients report symptom improvement
- Average 3-point reduction in HbA1c
- $1.18x return on investment (ROI)
- 80 Net Promoter Score (NPS), reflecting high patient satisfaction
These outcomes validate Ciba Health’s impact as both a scalable clinical solution and a cost-effective alternative to traditional chronic care models.
Among the report’s standout findings was the validation of Ciba Health’s GLP-1 Step Down Program, the first nationally structured solution designed to help members safely taper off GLP-1 medications, restore metabolic health, and avoid the rebound weight gain often experienced after discontinuation.
The Validation Institute confirmed that members who completed the program achieved an average weight loss of 30 pounds, reduced GLP-1 drug use by 85 percent, and contributed to more than 5.3 million dollars in prescription drug savings. These outcomes highlight the clinical and economic potential of combining structured tapering protocols with Ciba Health’s personalized root-cause metabolic care model.
To underscore its commitment to measurable value, Ciba Health offers a one hundred thousand dollar guarantee for clients who do not achieve documented ROI or savings within twelve months.
“Receiving validation from the Validation Institute is a powerful endorsement of our clinical approach,” said Dr. Innocent Clement, CEO of Ciba Health. “These findings confirm what we see every day in our patient outcomes. A personalized root-cause care model can reduce medication dependency, lower healthcare costs, and most importantly, help people heal and thrive. It is proof that whole-person care is both clinically effective and financially scalable.”
“Our validation confirmed significant reductions in drug spend, including GLP-1s, and measurable improvements in clinical outcomes. We and Ciba Health acknowledge a study limitation about comparing participants to non-participants. Nonetheless, the measurement methodology is more valid and conservative than the largest vendors in the diabetes space. Those methodologies could never receive validation,” said Al Lewis, CEO, Validation Institute. “Ciba Health’s commitment to delivering ROI for self-funded employers, TPAs and health plans is both impressive and impactful.”
Ciba Health’s results stem from its comprehensive, integrative AI-powered model: physician-led care teams, advanced diagnostics, wearable tracking, real-time insights, and a personalized program designed to target the root cause of chronic diseases.
Ciba Health partners with employers, health plans, health systems, TPAs, benefits consultants and providers to prevent and reverse common chronic health conditions. For more information or to learn about partnership opportunities, visit www.cibahealth.com.
ABOUT CIBA HEALTH
Ciba Health is a unified care platform powered by AI that prevents and reverses common, complex, and costly chronic diseases. Ciba Health simplifies chronic disease care delivery through predictive analytics, whole-person root-cause care, and personalized treatment plans that lead to sustainable health outcomes. Ciba Health is helping members who have cardiometabolic conditions, type 2 diabetes, prediabetes, autoimmune conditions, digestive disorders, and mental health challenges reverse their symptoms by 90% and cut medication usage by 85%. Ciba Health is helping employers, health plans, health systems, and providers improve the health of their populations and cut significant costs.
ABOUT VALIDATION INSTITUTE
Validation Institute is a professional community that advocates for organizations and approaches that deliver better health value – stronger health outcomes at lower cost. They connect, train, and certify health care purchasers, and validate and connect providers delivering superior results. Founded in 2014, the mission of the organization has consistently been to help provide transparency to buyers of health care.
MEDIA CONTACT
